TruogR.D.BrettA.S.FraderJ., “The Problem with Futility,”N. Engl. J. Med., 326 (1992): 1560–64.
2.
SchneidermanL.J.JeckerN.S.JonsenA.R., “Medical Futility: Response to Critiques,”Annals of Internal Medicine, 125 (1996): 669–674.
3.
TruogR.D., “Is It Time to Abandon Brain Death?”Hastings Center Report, 27, no. 1 (1997): 29–37; BernatJ.L., “A Defense of the Whole-brain Concept of Death,”Hasting Center Report, 28, no.2 (1998): 14–23.
4.
SolomonM.Z., “Decisions Near the End of Life: Professional Views of Life-Sustaining Treatments,”American Journal of Public Health, 82 (1993): 14–25.
5.
PopperK.R., The Logic of Scientific Discovery (New York: Harper & Row, 1968).
6.
RubenfeldG.D. and CrawfordS.W., “Withdrawing Life Support from Mechanically Ventilated Recipients of Bone Marrow Transplants: A Case for Evidence-based Guidelines,”Annals of Internal Medicine, 125 (1996): 625–633.
7.
SchneidermanL.J. and CapronA.M., “How Can Hospital Futility Policies Contribute to Establishing Standards of Practice?”Cambridge Quarterly of Healthcare Ethics, 9 (2000): 524–31.
8.
SchneidermanL.J., Letter to New England Journal of Medicine, 343 (2000): 1575–77.
9.
Gilgunn v. Massachusetts General Hospital, Mass. Sup. Ct., April 21, 1995. (No. 92-4820.)
10.
Schneiderman and Capron, supra note 7.
11.
Id.
12.
SchneidermanL.J.JeckerN.S., and JonsenA.R., “Medical Futility: Its Meaning and Ethical Implications,”Annals of Internal Medicine, 112 (1990): 949–54; SchneidermanL.J. and JeckerN.S., “Futility in Practice,”Archives of Internal Medicine, 153 (1993): 437–441; SchneidermanL.J. and JeckerN.S., Wrong Medicine: Doctors, Patients, and Futile Treatment, (Baltimore, MD: Johns Hopkins University Press, 1995).